From: Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis
irAEs (n = 53)
no-irAEs (n = 42)
P value
n
%
7
13.2
5
11.9
0.763a
32
60.4
29
69.0
0.381b